Concepedia

High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma

Axel Haferkamp, Jens Bedke, Caroline Vetter, Maria Pritsch, Nina Wagener, Stephan Buse, Irena Crnković‐Mertens, Karin Hoppe‐Seyler, Stephan Macher‐Goeppinger, Felix Hoppe‐Seyler,

British Journal of Urology · 2008 · 17 citations · 22 references

DOI

Abstract

High nuclear Livin expression is a favourable independent predictor of PFS and CSS in patients with RCC.

References

22

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.7K citations · Full text

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bernard Escudier, P. Koralewski, Alain Ravaud et al. · The Lancet · 2007 · 2.2K citations

, , +4

Rising Incidence of Renal Cell Cancer in the United States

Wong Ho Chow · JAMA · 1999 · 1.6K citations · Full text

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.

Richard I. Fisher, Steven A. Rosenberg, G. Fyfe · PubMed · 2000 · 441 citations